1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...

This prospective randomized clinical trial was approved by the Miami Veterans Affairs Medical Center Institutional Review Board and was HIPAA compliant. The study was registered with ClinicaTrials.gov ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a ...

If you don't like getting needles in the arm, imagine getting them in your eyes. That's what people with wet age-related macular degeneration have to do, but thanks to new research, those injections ...

CHICAGO — Specialists are losing money with every intravitreal injection they administer, regardless of the drug being injected, an investigator warns. Each injection we do costs $127.74 — $1.60 for ...

A father with a progressive eye disease was able to see his son thanks to a new therapy that uses a virus to bring a healthy gene into the eye CBS 17/YouTube A dad with the degenerative eye disease ...

Please provide your email address to receive an email when new articles are posted on . A 92-year-old Asian man was seen in the uveitis ophthalmology clinic due to 2 ...

Plotting a challenge to Regeneron’s blockbuster Eylea, Ocular Therapeutix has hired “a key architect” of its rival’s launch ...